Role of miR-145 in human laryngeal squamous cell carcinoma
- 17 October 2014
- journal article
- research article
- Published by Wiley in Head & Neck
- Vol. 38 (2) , 260-266
Abstract
Background Laryngeal squamous cell carcinoma (SCC), being an aggressive malignancy, is one of the most commonly diagnosed malignant types of head and neck SCC worldwide. Incidences of laryngeal SCC have been reported to increase recently. In this study, we aimed to explore the biological effects of miR-145 on laryngeal cancer cells. Methods The relative miR-145 level in laryngeal SCC tumor tissues and normal samples was investigated. Then, Hep-2 cells were utilized for functional analysis of miR-145. The proliferation abilities of transfected cells were measured using MTS assay. Scratch assay and single colony migration assay were performed to observe the alterations in migration behavior of transfected cells. Caspase assay and cell cycle analysis were used to investigate the underlying reasons of proliferative inhibition in cells in which miR-145 is overexpressed. Moreover, expression of SOX2 was analyzed using quantitative reverse transcription polymerase chain reaction (qRT-PCR) and Western blot analysis in Hep-2 cells upon miR-145 transfection and its expression was evaluated in tumor and normal tissue sample of the larynx. Results The miR-145 expression in laryngeal SCC tumor samples has been shown to be downregulated. The miR-145 overexpression caused inhibition of proliferation and migration in Hep-2 cells through induction of apoptosis and cell cycle arrest. The SOX2 level was demonstrated to be overexpressed in tumor samples and its expression was significantly decreased in miR-145 overexpressed Hep-2 cells. Conclusion We have demonstrated the deregulation of miR-145 and SOX2 in laryngeal SCC. Based on these results, we propose that miR-145, as an important regulator of SOX2, carries crucial roles in laryngeal SCC tumorigenesis. © 2015 Wiley Periodicals, Inc. Head Neck 38: 260–266, 2016Keywords
Funding Information
- The studies presented in this article are supported by The Scientific and Technological Research Council of Turkey. (210T009)
This publication has 24 references indexed in Scilit:
- MicroRNAs and human diseases: diagnostic and therapeutic potentialCell and tissue research, 2014
- MicroRNA profiling in lymphocytes and serum of tyrosinemia type-I patientsMolecular Biology Reports, 2013
- Retrospective Analysis of Prognostic Factors in 205 Patients with Laryngeal Squamous Cell Carcinoma Who Underwent Surgical TreatmentPLOS ONE, 2013
- Cancer statistics, 2013CA: A Cancer Journal for Clinicians, 2013
- Effects of tumour stage, comorbidity and therapy on survival of laryngeal cancer patients: a systematic review and a meta-analysisEuropean Archives of Oto-Rhino-Laryngology, 2010
- MicroRNA‐205–directed transcriptional activation of tumor suppressor genes in prostate cancerCancer, 2010
- MicroRNA145 Targets BNIP3 and Suppresses Prostate Cancer ProgressionCancer Research, 2010
- Laryngeal Cancer: Diagnosis and Preoperative Work-upOtolaryngologic Clinics of North America, 2008
- miRBase: tools for microRNA genomicsNucleic Acids Research, 2007
- EPIDEMIOLOGY OF LARYNGEAL CANCER1Epidemiologic Reviews, 1980